Expert Opinion on Drug Safety, Volume 14, Issue 1 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Safety, Volume 14, Issue 1 (2015)

See all volumes and issues
Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Volume 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Editorial

Editorial
Antipsychotic use in elderly patients and the risk of pneumonia
Giovanni Gambassi (Full Professor in Internal Medicine, Head) MD, Janet Sultana (PhD Student) & Gianluca Trifirò MD
Pages: 1-6
Published online: 28 Nov 2014
AbstractforAntipsychotic use in elderly patients and the risk of pneumonia | Full Text | References | PDF (149.9 KB)
  • 3612 Views
  • 28 CrossRef citations
  • 0Altmetric
Free Access

Original Research

Article
Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach
Paolo Verdecchia MD, Fabio Angeli MD, Claudia Bartolini MD, Valentina De Filippo MD, Adolfo Aita MD, Letizia Di Giacomo MD, Cristina Poltronieri MD, Gregory YH Lip MD & Gianpaolo Reboldi MD
Pages: 7-20
Published online: 14 Oct 2014
AbstractforSafety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach | Full Text | References | PDF (911.2 KB)
  • 1027 Views
  • 19 CrossRef citations
  • 0Altmetric
Article
Safety and efficacy of non-initial rapid infusion of rituximab plus chemotherapy in Chinese patients with CD20+ non-Hodgkin’s lymphoma
Wei Zhao, Yan Gao, Bin Bai, Qi-Chun Cai, Xiao-Xiao Wang, Qing-Qing Cai & Hui-Qiang Huang MD PhD
Pages: 21-29
Published online: 21 Nov 2014
AbstractforSafety and efficacy of non-initial rapid infusion of rituximab plus chemotherapy in Chinese patients with CD20+ non-Hodgkin’s lymphoma | Full Text | References | PDF (549 KB)
  • 328 Views
  • 3 CrossRef citations
  • 0Altmetric

Review

Safety considerations when using anti-TNFα therapy to treat Crohn’s disease
Cristiano Pagnini, Kristen O Arseneau & Fabio Cominelli
Pages: 31-44
Published online: 15 Nov 2014
AbstractforSafety considerations when using anti-TNFα therapy to treat Crohn’s disease | Full Text | References | PDF (230.7 KB)
  • 324 Views
  • 7 CrossRef citations
  • 0Altmetric
Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation
Mikhail S Dzeshka MD & Gregory YH Lip MD
Pages: 45-62
Published online: 24 Oct 2014
AbstractforWarfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation | Full Text | References | PDF (456.6 KB)
  • 577 Views
  • 4 CrossRef citations
  • 0Altmetric
Traceability of biologicals: present challenges in pharmacovigilance
Niels S Vermeer MSc, Irina Spierings BSc, Aukje K Mantel-Teeuwisse PhD, Sabine MJM Straus PhD, Thijs J Giezen PhD, Hubert GM Leufkens PhD, Toine CG Egberts PhD & Marie L De Bruin PhD
Pages: 63-72
Published online: 05 Nov 2014
AbstractforTraceability of biologicals: present challenges in pharmacovigilance | Full Text | References | PDF (274.4 KB)
  • 802 Views
  • 35 CrossRef citations
  • 0Altmetric
Weight gain and antipsychotics: a drug safety review
Richard Musil MD, Michael Obermeier, Paul Russ MD & Michael Hamerle MD
Pages: 73-96
Published online: 15 Nov 2014
AbstractforWeight gain and antipsychotics: a drug safety review | Full Text | References | PDF (679.4 KB) | Supplemental
  • 2567 Views
  • 128 CrossRef citations
  • 0Altmetric
Class act: safety comparison of approved tyrosine kinase inhibitors for non-small-cell lung carcinoma
Mauricio Burotto MD, Syed Abbas Ali MD & Geraldine O’Sullivan Coyne MD PhD MRCPI
Pages: 97-110
Published online: 25 Oct 2014
AbstractforClass act: safety comparison of approved tyrosine kinase inhibitors for non-small-cell lung carcinoma | Full Text | References | PDF (454.7 KB) | Supplemental
  • 587 Views
  • 7 CrossRef citations
  • 0Altmetric
Drug-induced uveitis
Miguel Cordero-Coma MD PhD FEBOphth, Raquel Salazar-Méndez MD, Irene Garzo-García MD & Taygan Yilmaz
Pages: 111-126
Published online: 17 Oct 2014
AbstractforDrug-induced uveitis | Full Text | References | PDF (415.3 KB)
  • 784 Views
  • 26 CrossRef citations
  • 0Altmetric
DPP-4 inhibitors: focus on safety
Sri Harsha Tella MD & Marc S Rendell (Executive Director) MD
Pages: 127-140
Published online: 09 Dec 2014
AbstractforDPP-4 inhibitors: focus on safety | Full Text | References | PDF (332.2 KB)
  • 2035 Views
  • 41 CrossRef citations
  • 0Altmetric

Drug Safety Evaluation

Evaluation of dolutegravir safety for the treatment of HIV-1
Susana W Keeshin (Assistant Professor of Medicine) MD & Judith Feinberg (Professor of Medicine) MD
Pages: 141-147
Published online: 27 Oct 2014
AbstractforEvaluation of dolutegravir safety for the treatment of HIV-1 | Full Text | References | PDF (244.1 KB)
  • 447 Views
  • 8 CrossRef citations
  • 0Altmetric
Linagliptin for the treatment of type 2 diabetes mellitus: a drug safety evaluation
Anthony H Barnett
Pages: 149-159
Published online: 29 Oct 2014
AbstractforLinagliptin for the treatment of type 2 diabetes mellitus: a drug safety evaluation | Full Text | References | PDF (401.1 KB)
  • 582 Views
  • 7 CrossRef citations
  • 0Altmetric
Dimethyl fumarate for treating relapsing multiple sclerosis
William Sheremata (Emeritus Professor of Neurology) MD FRCPC FACP FAAN, Andrew D Brown (Assistant Professor) (Fellow in Multiple Sclerosis) MD & Kottil W Rammohan (Professor of Clinical Neurology) MD
Pages: 161-170
Published online: 08 Nov 2014
AbstractforDimethyl fumarate for treating relapsing multiple sclerosis | Full Text | References | PDF (368.7 KB)
  • 793 Views
  • 27 CrossRef citations
  • 0Altmetric
Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes – focus on pancreatitis and pancreas cancer
Thor Chalmer, Thomas P Almdal, Tina Vilsbøll & Filip K Knop (Associate Professor, Consultant, Director of Center for Diabetes Research) MD PhD
Pages: 171-180
Published online: 03 Nov 2014
AbstractforAdverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes – focus on pancreatitis and pancreas cancer | Full Text | References | PDF (298.2 KB)
  • 806 Views
  • 20 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter
Dual opioid therapy using methadone as a coanalgesic
Akhila Reddy MD, Sriram Yennurajalingam MD & Eduardo Bruera MD
Pages: 181-182
Published online: 05 Nov 2014
First Page PreviewforDual opioid therapy using methadone as a coanalgesic | Full Text | References | PDF (111.6 KB)
  • 2468 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Further Readings

Related articles
Page: 1
Published online: 16 Dec 2014
CitationforRelated articles | Full Text | PDF (90.2 KB)
  • 65 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles